Ultra-Fast Dose Rate (FLASH) Radiation Detectors and Safety Systems for Cancer Treatment
ID: NIH/NCI 461Type: BOTH
Overview

Topic

Ultra-Fast Dose Rate (FLASH) Radiation Detectors and Safety Systems for Cancer Treatment

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: SBIRPhase: BOTHYear: 2023

Topic Link

https://www.sbir.gov/node/2451713

Additional Information

https://sam.gov/opp/aa72581c848947f0b61c15062e604862/view
Timeline
  1. 1
    Release Aug 25, 2023 12:00 AM
  2. 2
    Open Aug 25, 2023 12:00 AM
  3. 3
    Next Submission Due Nov 14, 2023 12:00 AM
  4. 4
    Close Nov 14, 2023 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC), is seeking proposals for Small Business Innovation Research (SBIR) contract proposals. The topic of the solicitation is "Ultra-Fast Dose Rate (FLASH) Radiation Detectors and Safety Systems for Cancer Treatment".

The research aims to develop radiation detectors that can accurately measure ultra-fast dose rates of 40-120 Gy/second, which is necessary for the implementation of FLASH radiation therapy in the clinic. Current devices lack the response times required for this level of dose rate.

The potential impact of this technology is significant, as FLASH radiation therapy has been shown to have fewer side effects compared to regular radiation therapy. The development of reliable radiation detectors will enable the safe utilization of FLASH treatment techniques in cancer treatment.

The solicitation is open for Fast-Track and Direct-to-Phase II proposals. The anticipated number of awards is 2-3, and the budget for Phase I is up to $400,000 for up to 12 months, while Phase II has a budget of up to $2,000,000 for up to 2 years. Proposals that exceed the budget or project duration may not be funded.

For more information and to submit a proposal, interested parties can visit the SBIR topic link at https://www.sbir.gov/node/2451713. The solicitation can be found at https://sam.gov/opp/aa72581c848947f0b61c15062e604862/view. The application due date is November 14, 2023.

Files
No associated files provided.
Similar Opportunities
DOD SBIR 24.4 Annual - Solid-State Scalable/Tileable Imaging Detector for High-Energy Neutron Radiography
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for a solid-state scalable/tileable imaging detector for high-energy neutron radiography. The objective is to deliver a state-of-the-art high-energy neutron radiography imaging/detector. The technology will be used in conjunction with a source of high-energy neutrons to achieve a state-of-the-art neutron radiography system. The project will consist of three phases. In Phase I, the proposer must prove the principle through a white paper study that demonstrates strong evidence that a solid-state neutron detector can be designed and constructed on a chip. In Phase II, the proposer will build and deliver a tiled detector with minimum dimensions of 11" square that is effective for 1 MeV neutrons. The detector should provide short acquisition imaging times, high contrast, high spatial resolution, and high signal-to-noise ratio. In Phase III, the proposer will explore dual-use applications of the technology. Potential applications include accurate and fast inspections of Army ammunition, armaments, and other products for quality, safety, and lethality. The technology could also be used for compact, lightweight, self-contained scalable detectors in the detection of materials that emit gamma/beta rays or sub-atomic particles, such as radioactive isotopes, contamination, and special nuclear material. Commercial applications could include ground stationary check points, aerial applications, and underground/underwater drilling/mining applications. The project duration is not specified, but the proposal submission deadline is March 31, 2025. More information can be found on the DOD SBIR website (https://www.defensesbirsttr.mil/SBIR-STTR/Opportunities/).
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of unlicensed products, or administration of licensed products for unapproved indications. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, study management and oversight, safety monitoring, and regulatory activities. The project duration is not specified, but the solicitation is open until January 14, 2027. The funding specifics can be found on the grants.nih.gov website.
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) topic. This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required). This solicitation aims to support Small Business Concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require Federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, safety monitoring, and regulatory activities. The project duration is not specified, but the application due dates are provided. More information can be found on the grants.gov website.